ArticleJournal of thoracic disease2026
Development and internal validation of a high-resolution computed tomography radiomics and three-dimensional deep learning diagnostic prediction model for preoperative differentiation of minimally invasive and invasive adenocarcinoma in subsolid nodules.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative differentiation between minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) in pulmonary subsolid nodules (SSNs) is important for surgical planning, but conventional computed tomography (CT) assessment and single-modality models have limited ability to characterize tumor heterogeneity. This study aimed to develop and internally validate high-resolution CT (HRCT)-based radiomics-deep learning (DL) fusion diagnostic prediction model for differentiating MIA from IAC. Methods: This retrospective single-center diagnostic prediction model development and internal validation study included 374 patients with surgically confirmed SSN-associated lung adenocarcinoma between September 2015 and June 2025, including 124 MIA and 250 IAC cases. Patients with single SSNs, preoperative HRCT, adequate image quality, and pathological confirmation were included, whereas those with solid nodules, multiple SSNs, poor-quality images, unclear pathology, or incomplete data were excluded. Three-dimensional (3D) lesions were manually segmented on HRCT. Radiomics features were extracted using PyRadiomics, and DL features were obtained from a pretrained 3D MedicalNet model. Radiomics-only, DL-only, and fusion models were developed using ElasticNet-regularized logistic regression and internally validated by stratified five-fold cross-validation and 1,000 bootstrap resampling. Results: The MIA and IAC groups had comparable age, sex, and smoking history, whereas IAC showed more frequent lobulation, spiculation, pleural indentation, larger nodule size, and higher solid component proportion. In internal validation, the radiomics-only, DL-only, and fusion models achieved area under the curves (AUCs) of 0.833, 0.887, and 0.937, respectively. The fusion model showed the best performance, with a sensitivity of 0.864, specificity of 0.807, and accuracy of 0.845, and demonstrated favorable calibration and decision-curve performance. Conclusions: This study provides preliminary proof-of-concept evidence that integrating HRCT-based radiomics and DL features may improve internal validation performance for differentiating MIA from IAC in SSNs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.